| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1367 | 2018 |
| Migraine: epidemiology and systems of care M Ashina, Z Katsarava, TP Do, DC Buse, P Pozo-Rosich, A Özge, ... The Lancet 397 (10283), 1485-1495, 2021 | 411 | 2021 |
| Genome-wide association analysis identifies susceptibility loci for migraine without aura T Freilinger, V Anttila, B De Vries, R Malik, M Kallela, GM Terwindt, ... Nature genetics 44 (7), 777-782, 2012 | 404 | 2012 |
| Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults C Tassorelli, HC Diener, DW Dodick, SD Silberstein, RB Lipton, M Ashina, ... Cephalalgia 38 (5), 815-832, 2018 | 306 | 2018 |
| Diagnosis and management of migraine in ten steps AK Eigenbrodt, H Ashina, S Khan, HC Diener, DD Mitsikostas, AJ Sinclair, ... Nature Reviews Neurology 17 (8), 501-514, 2021 | 300 | 2021 |
| Targeting calcitonin gene-related peptide: a new era in migraine therapy A Charles, P Pozo-Rosich The Lancet 394 (10210), 1765-1774, 2019 | 288 | 2019 |
| P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer F Graus, B Lang, P Pozo-Rosich, A Saiz, R Casamitjana, A Vincent Neurology 59 (5), 764-766, 2002 | 255 | 2002 |
| Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised … WM Mulleners, BK Kim, MJA Láinez, M Lanteri-Minet, P Pozo-Rosich, ... The Lancet Neurology 19 (10), 814-825, 2020 | 239 | 2020 |
| Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution E Caronna, A Ballvé, A Llauradó, VJ Gallardo, DM Ariton, S Lallana, ... Cephalalgia 40 (13), 1410-1421, 2020 | 222 | 2020 |
| Voltagegated potassium channel antibodies in limbic encephalitis P PozoRosich, L Clover, A Saiz, A Vincent, F Graus Annals of Neurology: Official Journal of the American Neurological …, 2003 | 212 | 2003 |
| Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults HC Diener, C Tassorelli, DW Dodick, SD Silberstein, RB Lipton, M Ashina, ... Cephalalgia 39 (6), 687-710, 2019 | 205 | 2019 |
| Migraine: integrated approaches to clinical management and emerging treatments M Ashina, DC Buse, H Ashina, P Pozo-Rosich, MFP Peres, MJ Lee, ... The Lancet 397 (10283), 1505-1518, 2021 | 185 | 2021 |
| Cluster headache A May, TJ Schwedt, D Magis, P Pozo-Rosich, S Evers, SJ Wang Nature reviews Disease primers 4 (1), 1-17, 2018 | 177 | 2018 |
| European headache federation consensus on the definition of resistant and refractory migraine: Developed with the endorsement of the European Migraine & Headache Alliance (EMHA) S Sacco, M Braschinsky, A Ducros, C Lampl, P Little, AM Van Den Brink, ... The journal of headache and pain 21, 1-12, 2020 | 155 | 2020 |
| Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes F Graus, A Vincent, P Pozo-Rosich, L Sabater, A Saiz, B Lang, J Dalmau Journal of neuroimmunology 165 (1-2), 166-171, 2005 | 141 | 2005 |
| Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation L Bendtsen, S Sacco, M Ashina, D Mitsikostas, F Ahmed, P Pozo-Rosich, ... The Journal of Headache and Pain 19, 1-10, 2018 | 140 | 2018 |
| Tension-type headache S Ashina, DD Mitsikostas, MJ Lee, N Yamani, SJ Wang, R Messina, ... Nature Reviews Disease Primers 7 (1), 24, 2021 | 133 | 2021 |
| Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults HC Diener, C Tassorelli, DW Dodick, SD Silberstein, RB Lipton, M Ashina, ... Cephalalgia 40 (10), 1026-1044, 2020 | 129 | 2020 |
| Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: the multicentre, double-blind, randomised, sham-controlled PREMIUM trial HC Diener, PJ Goadsby, M Ashina, MAM Al-Karagholi, A Sinclair, ... Cephalalgia 39 (12), 1475-1487, 2019 | 99 | 2019 |
| Common variant burden contributes to the familial aggregation of migraine in 1,589 families P Gormley, MI Kurki, ME Hiekkala, K Veerapen, P Häppölä, AA Mitchell, ... Neuron 98 (4), 743-753. e4, 2018 | 97 | 2018 |
